Home / Companies / Fortrea Inc F K A Labcorp Drug Development Inc / Trends
Fortrea Inc F K A Labcorp Drug Development Inc H-1B trends
Quarterly LCA aggregate trend points for Fortrea Inc F K A Labcorp Drug Development Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Fortrea Inc F K A Labcorp Drug Development Inc span 2023 Q3 to 2026 Q2, peaking at 6 filings in 2025 Q4.
The most recent reported period (2026 Q2) shows 3 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 2 | 2 | 2 | $131,500 | $101,827 | 2 | 100.0% |
| 2023 Q4 | 2 | 2 | 1 | $142,000 | $123,677 | 2 | 100.0% |
| 2025 Q1 | 2 | 2 | 1 | $140,000 | $92,269 | 2 | 100.0% |
| 2025 Q2 | 2 | 1 | 1 | $133,000 | $96,606 | 2 | 100.0% |
| 2025 Q3 | 5 | 5 | 4 | $133,000 | $106,209 | 5 | 100.0% |
| 2025 Q4 | 6 | 3 | 4 | $158,959 | $140,785 | 6 | 100.0% |
| 2026 Q2 | 3 | 2 | 3 | $139,333 | $122,616 | 3 | 100.0% |
Frequently asked questions
- How have H-1B filings for Fortrea Inc F K A Labcorp Drug Development Inc changed over time?
- H-1B LCA filings for Fortrea Inc F K A Labcorp Drug Development Inc span 2023 Q3 to 2026 Q2, peaking at 6 filings in 2025 Q4. The most recent reported period (2026 Q2) shows 3 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=fortrea+inc+f+k+a+labcorp+drug+development+inc&metric=lca_countJSON